Functional genomics reveals that Clostridium difficileSpo0A coordinates sporulation, virulence and metabolism
- Laura J Pettit†1,
- Hilary P Browne†1,
- Lu Yu†1,
- Wiep Klaas Smits2,
- Robert P Fagan3,
- Lars Barquist1, 4,
- Melissa J Martin1,
- David Goulding1,
- Sylvia H Duncan5,
- Harry J Flint5,
- Gordon Dougan1,
- Jyoti S Choudhary1 and
- Trevor D Lawley1, 6Email author
© Pettit et al.; licensee BioMed Central Ltd. 2014
Received: 30 September 2013
Accepted: 14 February 2014
Published: 25 February 2014
Clostridium difficile is an anaerobic, Gram-positive bacterium that can reside as a commensal within the intestinal microbiota of healthy individuals or cause life-threatening antibiotic-associated diarrhea in immunocompromised hosts. C. difficile can also form highly resistant spores that are excreted facilitating host-to-host transmission. The C. difficile spo0A gene encodes a highly conserved transcriptional regulator of sporulation that is required for relapsing disease and transmission in mice.
Here we describe a genome-wide approach using a combined transcriptomic and proteomic analysis to identify Spo0A regulated genes. Our results validate Spo0A as a positive regulator of putative and novel sporulation genes as well as components of the mature spore proteome. We also show that Spo0A regulates a number of virulence-associated factors such as flagella and metabolic pathways including glucose fermentation leading to butyrate production.
The C. difficile spo0A gene is a global transcriptional regulator that controls diverse sporulation, virulence and metabolic phenotypes coordinating pathogen adaptation to a wide range of host interactions. Additionally, the rich breadth of functional data allowed us to significantly update the annotation of the C. difficile 630 reference genome which will facilitate basic and applied research on this emerging pathogen.
KeywordsClostridium difficile Spo0A RNAseq Proteomics Sporulation Virulence Metabolism Butyrate Transmission Genome annotation
Clostridium difficile has emerged over the past decade to become the most common cause of infectious antibiotic-associated diarrhea within healthcare systems worldwide . This Gram-positive, anaerobic bacterium commonly resides asymptomatically in healthy individuals who can serve as a transmission reservoir within a hospital setting . The emergence of C. difficile virulence is linked to the acquisition of multiple resistance determinants to commonly used antibiotics [3–6] allowing this pathogen to thrive in the intestines of patients following antibiotic treatment . C. difficile can produce a number of potent virulence-associated factors that contribute to intestinal colonization and disease , and facilitate the establishment of a pathological imbalance within the resident microbiota . Unlike many other healthcare pathogens, C. difficile produces highly resistant and transmissible spores and, as a consequence, creates significant challenges to infection control and environmental decontamination protocols .
Sporulation is a complex developmental program leading to the generation of metabolically dormant spores from vegetative cells . Spo0A is a transcription factor that is active in the early stages of sporulation in C. difficile and other sporulating bacteria . Orthologues of Spo0A are encoded by a variety of the Firmicutes , including Bacillus and Clostridium, and the genetic inactivation of this gene leads to a non-sporulating phenotype [14, 15]. In the well studied Clostridium and Bacillus organisms, many of the pleiotropic effects of Spo0A are due to indirect regulation via the transition state regulator AbrB [16–20]. However, C. difficile does not encode an AbrB orthologue highlighting differences in Spo0A activity between C. difficile and other Clostridium and Bacillus species studied to date [5, 21]. C. difficile Spo0A binds directly to DNA upstream of several early sporulation genes  but this transcriptional regulator may also control other processes not obviously associated with sporulation. For example, in C. difficile Spo0A has also been implicated in controlling toxin gene expression  and disease in mice [15, 23] and biofilm formation in vitro[24, 25].
Consequently, we performed a genome-wide analysis to define Spo0A regulated genes within C. difficile using a combined transcriptomic and proteomic approach. Our analysis demonstrates that the C. difficile spo0A gene encodes a global transcriptional regulator that coordinates an array of phenotypes associated with host colonization and transmission. The rich breadth of our functional data allowed us to make significant updates to the annotation of the C. difficile 630 reference genome.
C. difficile growth dynamics in vitro
Western blot analysis using C. difficile Spo0A-specific antibodies demonstrated that Spo0A was produced during both exponential and stationary growth by C. difficile 630Δerm but not a spo0A mutant derivative (Figure 1b). Given our interest in defining the genes controlled by C. difficile Spo0A and the potential links between sporulation and other phenotypes we chose to focus on mid-exponentially growing C. difficile (vertical gray arrow in Figure 1a) for subsequent experiments.
Functional enrichment of the C. difficile630 genome annotation with transcriptomics and proteomics
To survey and compare the global transcriptomes of C. difficile 630Δerm and the spo0A mutant we performed high-density, strand-specific cDNA sequencing (RNAseq) of RNA extracted from exponentially growing cultures and mapped the sequence data to the C. difficile 630 genome [5, 30]. Next we normalised the mean abundance of reads per gene (Additional file 1) and identified 321 genes that were differentially expressed (P-adjusted value < 0.01) in the spo0A mutant, of which 164 were upregulated and 157 were downregulated compared to C. difficile 630Δerm (Additional file 2). Genes whose expression was influenced by Spo0A (either positively or negatively) were evenly distributed around the genome and were encoded on both the forward and reverse strands (data not shown).
Our combined transcriptomic and proteomic dataset comparing the 630Δerm and the spo0A mutant derivatives provided a unique opportunity to enrich the current genome annotation of the reference C. difficile 630, particularly for those genes that were previously annotated as “conserved hypothetical” based on in silico predictions [5, 30]. This study represents the largest functional analysis of the reference C. difficile 630 genome since its creation in 2006  and builds upon previous annotation updates  by validation of the implicated genes that is not possible by in silico methods.
The improved annotation described here is primarily based on the presence of differentially expressed genes in the RNAseq and proteomic datasets (this study) or the mature spore proteome  datasets (Additional file 2). For those genes implicated in the experimental dataset that did not have a known functional product, in silico annotation was undertaken to predict a function. This utilised searches on nucleotide and amino acid sequences of homologous genes and prediction of protein family and domain sites with the Pfam database  and Prosite database  in addition to identifying subcellular localisation of proteins using SignalP  and THMMM . This process was also complemented by literature searches relating to the functional characterisation of the genes and their products in question. A feature of any annotated genome is that it is current only at the time it was created. In light of this in silico annotation as described above was also performed on all genes without a known product that were not present in the experimental dataset.
Correspondingly the functional classes characterising genes of an unknown or a putative function i.e. ‘hypothetical’ (class 0.0.0), ‘conserved hypothetical’ (class 0.0.2) and ‘uncharacterised’ (class 7.0.0), have all decreased in number except for class 0.0.2. However 92 of these genes were not identified in the initial 2006 annotation (Figure 3) and a further 133 were initially part of class 0.0.0 and have been moved to class 0.0.2 representing annotation studies on subsequent C. difficile strains. As a result, there are now only 3 genes in class 0.0.0 (CD2933, CD2947A and CD3148).
In total 662 genes were differentially expressed in the spo0A RNAseq, spo0A proteome or the mature spore proteome datasets representing 17% of the entire C. difficile 630 gene content. 11 of the 662 differentially expressed genes that previously were classified as 0.0.2 or 7.0.0 now have a known function, these include 4 spore coat associated genes: CD1433 (cotE), CD1511 (cotB), CD1567 (cotG) and CD1613 (cotA) [36, 37]. The presence of 68 genes in the experimental dataset that previously resided in class 0.0.2 are now updated to class 7.0.0 confirming their expression. Interestingly, 6 genes that were previously classified as pseudogenes due to the presence of frameshifts or mobile genetic elements have been changed to functioning genes based on their presence in the experimental dataset. 2 of these (CD0816 and CD1718) are interrupted by IStrons. The ability of the IStron to be excised from the mRNA transcript and not interfere with gene functionality [38, 39] is corroborated by the presence of these genes in the experimental dataset.
In silico annotation of genes in classes 0.0.0, 0.0.2 and 7.0.0 that were not present in the experimental dataset also resulted in considerable improvements to the elucidation of gene products. 24 genes previously contained in these classes are now in a known functional class. The classification of 9 more genes has improved from class 0.0.2 to class 7.0.0. In addition to this a further 5 genes (CD0606, CD1499, CD1570, CD1820 and CD2553), previously classified as pseudogenes due to been interrupted by IStrons have been restored to functional genes. All of these improvements are representative of a broad range of functional classes.
Now 3409 out of the 3897 genes in the C. difficile 630 genome have either a known or putative function or experimental evidence confirming the gene is expressed. Other significant improvements to the annotation include the re-classification of sigK (CD1230) as a functional gene; the presence of the skin prophage-like element which interrupts the gene is not detrimental to gene functionality due to controlled excision .
In addition to identifying gene products, gene nomenclatures have been updated where possible. Gene nomenclatures for 26 of the cell wall proteins (cwp)  have been added as well as the cationic peptide resistance cluster cprA,B,C and its regulators cprR and cprK[42, 43]. Gene names for the extra cytoplasmic sigma factors csfU,V,T and the associated anti-sigma factors rsiU,V,T which are involved in sensing and responding to extracellular stresses  have also been added. Finally, duplicate gene names have been resolved where appropriate by the addition of a number or letter.
The annotation has been updated on the main genomic sequence repositories (accession no. AM180355) and the embl file can also be accessed at http://www.sanger.ac.uk/resources/downloads/bacteria/clostridium-difficile.html which contains all of the functional class annotations described here. Subsequent analysis in this manuscript was performed using the newly annotated C. difficile 630 genome.
Genome-wide functional classification of the Spo0A regulated genes
Several genes that were previously shown to harbor a consensus Spo0A binding site upstream of their coding sequences  were differentially regulated in the spo0A mutant at the transcript or protein level. For instance, Spo0A binds to the upstream region of ssuA, which shows significantly lower RNA and protein levels in the spo0A mutant compared to wild type (Additional file 2). Similarly, the putative direct target lplA shows increased levels of RNA and protein. Thus, these genes are likely direct targets of Spo0A in C. difficile. We found that many genes with altered transcript levels do not contain a consensus Spo0A binding motif . These may either reflect regulation through a non-consensus Spo0A-binding motif, or indirect regulation. It is noteworthy that several putative transcriptional regulators show changes in transcript levels (Additional file 3) and strong Spo0A dependent regulation without the presence of a clear Spo0A binding site has previously been noted for Clostridium acetobutylicum.
Overall, these data indicate the C. difficile Spo0A directly and indirectly regulates a diverse set of genes potentially linked to different phenotypes beyond sporulation.
Spo0A positively regulates the sporulation cascade
Phosphorylation of Spo0A leads to the activation of a sigma factor cascade that acts in both mother cell and forespore (Figure 5) and many of the early stage B. subtilis sporulation proteins are highly conserved in C. difficile 630 genome, including the sporulation specific sigma factors SigH, SigF, SigG, SigE, SigA2 and SigK . We found that Spo0A influenced the expression of the sigE, sigG, sigF and sigA2 genes that were relatively under represented in the spo0A mutant. Taken together, these data suggest that in C. difficile Spo0A positively controls the expression of SigF, SigG, SigA2 and SigE during the early stages of sporulation (Figure 5).
Our data indicates that the role of Spo0A in regulating the formation of endospores is relatively conserved between B. subtilis and C. difficile. However, based on genomic and proteomic comparisons the later stages (cortex, coat and release; stages IV and V: reviewed in ) of sporulation appear to be less conserved. We found the three transcriptional units encoding early sporulation genes previously predicted to be direct targets of Spo0A in C. difficile, spoIIAA-AB-AC/sigF, spoIIGA-sigG-sigE and spoIIE, were under represented in the spo0A mutant. The list of significantly affected genes also includes SigE-dependent genes, such as spoIIID and the spoIIIAA-AH operon. Of all of these stage II and III genes in the Spo0A regulon, only SigG is found in the mature spore (Additional file 2).
It should be noted that our analysis did not identify many of the conserved later-stage IV and V genes  as differentially expressed in the spo0A mutant, likely due to the growth conditions. Many of these are controlled by the late sporulation sigma factor SigK, and consistent with this we observed no effect of a spo0A mutation on sigK transcription under our experimental conditions. The exceptions are spoIVA, spoVD, cspBA-cspC and sipL which are under control of SigE . We also identified the genes encoding the subtilisin like protease CspBA , the germinant receptor CspC , and the spore morphogenetic protein SipL  as differentially expressed in the spo0A mutant.
Spo0A regulates colonization and virulence genes
Our analysis revealed that distinct functional classes linked to C. difficile virulence and colonization are under control of Spo0A. Consistent with our previous studies , the toxin gene tcdA was significantly upregulated in the C. difficile spo0A mutant (Additional file 2). We could not identify a consensus ‘0A’ binding box upstream of the tcdA start site and in vitro binding assays did not indicate that tcdA was a direct target of Spo0A . Thus, Spo0A appears to indirectly control tcdA gene expression, perhaps via one of the many other factors that control toxin gene expression [53–56]. Our analyses were carried out on cells in exponential growth phase, where toxin expression is lower compared to stationary growth phase . This may in part explain the fact that the tcdB gene (which is expressed at much lower levels than tcdA[56, 58] was not identified as differentially expressed.
Our data suggests that Spo0A exerts significant control over the C. difficile cell envelope architecture and associated structures (Figure 4a and b), several of which are implicated in intestinal adherence, colonisation or subversion of the hosts’ immune system. For example, six genes encoding surface proteins showed altered transcription in the spo0A mutant; cwp10, CD2797 and CD3246 are upregulated in the spo0A mutant whereas cwp19, cwp27 and cwp29 are all downregulated. Two of these, CD2797 and CD3246 possess adherence-associated domains while the remaining four (cwp10, cwp19, cwp27 and cwp29) encode members of the cell wall protein family . Several genes implicated in remodeling of the cell wall are also regulated by Spo0A. For example, uppS1 encodes an undecaprenyl-pryophosphate synthase responsible for synthesizing a cell wall carbohydrate lipid precursor, and is downregulated in the spo0A mutant. Two genes in the dlt alanylation operon, dltA and dltB, were significantly upregulated in the spo0A mutant. These later two genes are located within a four-gene operon involved in the esterification of teichoic acid or lipoteichoic acid with D-alanine, conferring resistance to cationic antimicrobial peptides .
In C. difficile 630, components of the flagellar assembly apparatus are encoded by two loci that are divided by an inter-flagellar locus that has been implicated in flagellin glycosylation. Fourteen genes encoding flagellar proteins (fliC, fliE, fliF, fliG, fliH, fliI, fliJ, fliK, fliW, fliZ, flbD, flgB, flgD and motB) and the four transcripts (CD0241-CD0244) that constitute the inter-flagellar glycosylation locus  were relatively upregulated in the spo0A mutant at the mRNA level (Additional file 2). However, the differences in expression of the flagella structural genes were not reflected in the proteomic data and this is likely due to loss of the flagella from bacterial cells during sample preparation.
We could not identify a consensus Spo0A binding motifs immediately upstream of the Spo0A-affected cell membrane/wall associated genes, with the exception of putative CD0241-0244 operon . This indicates that the majority of the effects of Spo0A on this class of genes are either mediated by degenerate motifs or indirectly via one or more of the Spo0A-affected transcriptional regulators (Additional file 3).
C. difficileSpo0A is a positive regulator of butyrate biosynthesis
Glucose fermentation can lead to the production of a variety of metabolic by-products including butyrate (glucose is the only carbohydrate in the growth medium). Interestingly, we found that the entire butyrate production operon  was downregulated in the C. difficile spo0A mutant at both the mRNA and protein levels (Additional file 2), including butyryl-CoA dehydrogenase (bcd2), electron transfer flavoprotein β-subunit (etfB3), electron transfer flavoprotein α-subunit (etfA3), 3-hydroxybutyryl-CoA dehydratase (crt2), 3-hydroxybutyryl-CoA dehydrogenase (hbd) and acetyl-CoA acetyltransferase (thlA1). Figure 7 illustrates a proposed biochemical pathway for glucose uptake and fermentation highlighting in red those genes under positive control of Spo0A. Key components of this butyrate production pathway are also present in the C. difficile 630 spore proteome , suggesting a possible association between butyrate and spore formation and/or germination in C. difficile. None of the genes listed above harbor a consensus Spo0A binding site in their immediate upstream region. Interestingly, ptb and buk, encoding a phosphate butyryltransferase and a butyrate kinase, respectively, were upregulated in the spo0A mutant at the mRNA level. These two genes are potentially directly regulated by Spo0A; the upstream region of ptb contains a Spo0A box  and the buk gene likely forms an operon with ptb.
To determine which of these transcriptional responses dominates the butyrate biosynthetic pathway we measured butyrate from exponentially growing C. difficile 630Δerm and the spo0A mutant. We found that the C. difficile spo0A mutant produced significantly less butyrate than the parental 630Δerm (P = 0.0005; Figure 7). Moreover, the spo0A mutant complemented in trans with a plasmid borne spo0A gene produced levels of butyrate that were statistically comparable with the 630Δerm parental strain (P = 0.6; Figure 7). Thus, overall C. difficile Spo0A positively controls butyrate production, likely via an indirect mechanism.
C. difficile Spo0A is generally considered a transcriptional regulator of sporulation although recent reports have suggested additional roles in toxin gene regulation in vitro[15, 23] and intestinal colonization and disease in mice . Here we demonstrate an unappreciated role for C. difficile Spo0A as a global transcriptional regulator of colonization, virulence, sporulation and metabolic phenotypes. Thus, Spo0A influences all aspects of the C. difficile infection cycle allowing the bacterium to adapt to changing environments experienced during infection and host-transmission. The wide array of phenotypic defects in the C. difficile spo0A mutant would explain our previous results demonstrating that the C. difficile spo0A gene is required for persistent colonization and disease in mice .
Spo0A is a transcriptional regulator that is activated via phosphorylation from a cognate membrane-associated sensor histidine kinase(s) in response to an environmental cue(s). Underwood et al. demonstrated that the histidine kinase CD2492 can potentially serve as a phosphorylation donor for C. difficile Spo0A and proposed that other histidine kinases (i.e. CD1492 and CD1579) may also interact with Spo0A suggesting multiple environmental inputs. The environmental cues that lead to C. difficile Spo0A phosphorylation remain unknown but we predict such cues to be mainly present within the mammalian intestinal tract when C. difficile is metabolically active. Further, we propose such environmental cues influence an array of physiological states and phenotypes during the complete C. difficile lifecycle since Spo0A is present in the mature spore  and during all stages of vegetative growth .
C. difficile sporulation in the laboratory seems to occur asynchronously [28, 49, 50]. Though our sampling timepoint likely covers multiple growth stages, we cannot exclude the possibility that specific early or late timepoint-specific effects of Spo0A are missed in our analyses. Indeed, as a result of our choice of timepoint, late sporulation genes are underrepresented in our study. However, several studies have specifically addressed the role of Spo0A and the downstream sporulation specific sigma factors in the sporulation program [28, 29, 50]. Our genome and proteome analysis provides an excellent starting point to discriminate genes under direct or indirect control of Spo0A in C. difficile. We find that Spo0A affects the expression of several regulators (Additional file 3), suggesting that many of the observed effects may be indirect. Future research will focus on defining those environmental cues and associated histidine kinases that lead to Spo0A phosphorylation and the downstream genes that are under direct control of Spo0A-P to delineate the C. difficile Spo0A regulon.
Our study defined Spo0A-dependent gene expression patterns and phenotypes that allow us to speculate on C. difficile’s lifestyle within the intestinal tract. For example, Spo0A negatively regulates the sporulation cascade and surface proteins proposed to promote host interactions (i.e. CD2797 and CD3246) in addition to negatively regulating virulence factor expression (flagella and Toxin A). Perhaps during sporulation C. difficile downregulates some virulence and motility functions to avoid host surveillance while adhering to the mucosal surface. Indeed, we routinely observe C. difficile sporulating on the mucosal surface within the murine intestinal tract [62, 63]. Spo0A also coordinates shifts in nutrient transporters and metabolic pathways perhaps in response to the available nutrients on the mucosal surface such as complex and simple carbohydrates within the mucus layer overlying the intestinal epithelial cells . Spo0A also positively regulates butyrate production, a significant energy source for intestinal epithelial cells , potentially representing a metabolic link between C. difficile and the host to promote mucosal adherence. It is of note that several of the genes and programs identified in our study were also found to be Spo0A dependent in C. acetobutylicum[45, 66], suggesting that these are conserved and physiologically relevant patterns.
Even though we linked C. difficile Spo0A to distinct physiological states and phenotypes the vast majority of genes misregulated in a C. difficile spo0A mutant are of putative or hypothetical function due to the lack of knowledge about C. difficile biology and host interactions. The rich breadth of transcriptome and proteome data provided a unique opportunity to perform a significant functional annotation to the C. difficile 630 reference genome. With the recent description of genetic mutagenesis methods [14, 52] and murine infection models [62, 67, 68] the updated genome annotation will facilitate studies into C. difficile colonization, disease and transmission.
The C. difficile spo0A gene is a global transcriptional regulator that controls diverse sporulation, virulence and metabolic phenotypes coordinating pathogen adaptation to a wide range of host interactions. Additionally, the rich breadth of functional data allowed us to significantly update the annotation of the C. difficile 630 reference genome which will facilitate basic and applied research on this emerging pathogen.
Bacterial strains and growth conditions
C. difficile strains 630Δerm, 630Δerm spo0A::ermB (named the spo0A mutant in this manuscript) and 630Δerm spo0A::ermB + pspo0A were previously described . C. difficile was grown at 37°C under anaerobic conditions in a MACS MG-500 anaerobic workstation (Don Whitley Scientific). C. difficile was routinely cultured in Wilson’s broth plus 1% glucose with agitation (80 rpm) or on CCEY agar (Bioconnections) supplemented with cycloserine (250 μg/ml; Bioconnections), cefoxitin (8 μg/ml; Bioconnections) and 0.1% taurocholate (Sigma Aldrich) for 24 to 48 hours. For the enumeration of spores, C. difficile cultures were mixed with 100% ethanol (1:1 ratio) for 1 h at room temperature to kill vegetative cells, pelleted, washed in PBS and cultured as above.
Proteins resolved by SDS-PAGE were electrophoretically transferred to a nitrocellulose membrane at 30 V for 1 h. Protein transfer was visualised by staining in Ponseau-S Red (Sigma Aldrich) for 2 min, and membranes were blocked in blocking buffer (5% milk powder in 0.1% PBS-T) for 1 h at room temperature. Membranes were then probed with a Spo0A primary antibody (1/10,000)  overnight at 4°C, washed, and detected with an appropriate HRP-conjugated secondary antibody (1/10,000) for 1 h at room temperature. Proteins were revealed by chemiluminescence detection according to the Amersham ECL system (GE Healthcare), as per the manufacturer’s instructions.
RNA preparation and cDNA synthesis
Total RNA isolation and cDNA synthesis was performed as previously described . Briefly, three biological replicates of C. difficile culture (~1010 total cells) from exponentially growing cells were harvested in RNAProtect (Qiagen) according to the manufacturer’s protocol. Total RNA was extracted by chemical and mechanical lysis using a FastRNA Pro Blue Kit (MP Biomedicals) and FastPrep ribolyser, according to the manufacturer’s recommendations. Total RNA was purified using the SV RNA Isolation Purification Kit (Promega) according to the manufacturer’s instructions. Genomic DNA was removed from total RNA samples using one treatment of Turbo DNase (Ambion) according to the manufacturer’s recommendations. RNA quantification and integrity was determined using both a ND-1000 (NanoDrop Technologies) and 2100 Bioanalyser (Agilent Technologies). Samples were screened for the presence of genomic DNA using primer pairs CD1498 F: GATTGCAGATGCATGTGGTT and CD1498 R: TTGGAGAGCAAGAACAGCAA, CD1455 F: GATGCAGAGGCAATTTCACA and CD1455 R: GCTAGAAGGATGCACGAAGG, CD0011F: CCAGCTTTGCAACACCAACT and CD0011 R: GGCTATGGAGGCTTCTTATGG, and adk F: TTACTTGGACCTCCAGGTGC and adk R: GCAGCCTTAGGAAGTGGAAA. Equal amounts of DNA-free RNA (5 μg) was reverse transcribed to complementary DNA (cDNA) as follows. 20 μg RNA was incubated with 3 μg random hexamers and RNaseOUT ribonuclease inhibitor in a total volume of 16.4 μl, at 70°C for 10 min and then cooled on ice. For cDNA synthesis, 6 μl First Strand buffer, 0.6 μl dNTP mix (25 mM each dATP, dCTP, dGTP, dATP), 0.4 μl actinomycin D (1.2 mg/ml), 3 μl DTT (0.1 M) and 2 μl Superscript III were added to a total volume of 33 μl. Second strand cDNA synthesis was not performed in order to retain the strand specific sequence determination . Samples were then incubated for 2 h at 42°C, following which RNA was hydrolysed with 1.5 μl NaOH (1 M) for 20 min at 70°C. Finally, samples were neutralised with 1.5 μl HCl (1 M) and cDNA was purified using a G50-Sephadex column (Sigma-Aldrich), according to manufacturer’s instructions. Samples were screened for the presence of cDNA using specific primer pairs (above).
Library construction and sequencing
Libraries were constructed by shearing the purified cDNA using a Covaris LE220 focused ultrasonicator to give fragments in the range of 150–250 bp. This was followed by an end-repair incubation with T4 DNA polymerase, Klenow polymerase and T4 polynucleotide kinase (to phosphorylate blunt-ended fragments) for 30 min at 20°C. cDNA samples were then 3′ adenosine-tailed via the addition of Klenow exo- and dATP for 30 min at 37°C to reduce concatamerisation. Illumina adaptors (containing complementary sites to oligonucleotide anchors on the flow cell surface and primer sites for sequencing) were then ligated onto the cDNA repaired ends, and ligated fragments were electrophoretically separated from any unligated adapters based on size-selection. Fragments were then isolated via gel extraction. Libraries were amplified via PCR (18 cycles), quantified and denatured with 2 M NaOH to generate single stranded cDNA for sequencing. Samples were then loaded onto an Illumina flow cell to which the samples hybridise to the lawn of complementary oligonucleotide primers. Flow cell primers were then extended for 75 sequencing cycles, ultimately yielding clusters of clonally amplified cDNA templates. All steps were performed according to the manufacturer’s recommendations.
Transcripts were mapped using SMALT (http://www.sanger.ac.uk/resources/software/smalt/). Differential expression analysis was performed using R version 3.0.0 and DESeq statistical analysis package . For comparison with proteomic data, moderated log-fold changes were calculated using the variance stabilizing transformation supplied by Deseq. P-values were corrected for multiple testing using the Benjamini–Hochberg method, and a q-value threshold of 0.01 was used to identify differentially regulated genes with an expected false discovery rate of 10% (see Additional file 1).
Protein extraction and in-gel digestion
Three biological replicates of C. difficile 630 wild-type, C. difficile 630Δerm and C. difficile 630ΔermΔspo0A cultures were prepared. Briefly, ~1010 cells from exponentially growing C. difficile were harvested by centrifugation, resuspended in 300 μl lysis buffer (8 M urea, 2 M thiourea, 4% sodium dodecyl sulphate (SDS), 20 mM tris(2-carboxyethyl)phosphine (TCEP) in PBS) and incubated at 70°C for 10 min. Cells were then mechanically disrupted using acid-washed glass beads (size 425–600 μm; Sigma Aldrich) and a FastPrep ribolyser. The lysate supernatant was collected and clarified by centrifugation at 14,000 rpm for 30 min. Finally, samples were alkylated with a final concentration of 5 mM idoacetamide (IAA; Sigma-Aldrich). Samples with an equivalency to ~2 × 107 cells were loaded to a 12% Bis-Tris NuPAGE gel (Invitrogen) for protein separation. 18 bands were excised from each sample lane followed by in-gel digestion with trypsin in 50 mM TEAB. Peptides were extracted by 50% acetonitrile/0.5% formic acid and dried in a SpeedVac. For one of the biological replicate, three technical replicates from the SDS-PAGE step were prepared such that were five replicates in total for proteomic analysis.
Peptide dimethyl labelling and LC-MS/MS analysis
The dried peptides were derivatized with dimethyl triplex with cross-labelling using the standard in-solution protocol by Boersema , i.e. all primary amine (the N-terminus and the side chain of lysine residues) were converted to dimethylamines through reaction with formaldehyde (light), formaldehyde-D2 (intermediate) or formaldehyde-13C-D2 (heavy) and cyanoborohydride (light and intermediate) or cyanoborodeuteride (heavy).
The differentially labelled samples were mixed correspondingly before the nanoLC-MS/MS analysis on a LTQ Orbitrap Velos (Thermo Fisher) hybrid mass spectrometer equipped with a nanospray source, coupled with an Ultimate 3000 RSLCnano System (Dionex). The system was controlled by Xcalibur 2.1 (Thermo Fisher) and DCMSLink 2.08 (Dionex). Only 1/3 of total volume of each sample was submitted to analysis. Samples were first loaded and desalted on a PepMap C18 trap (0.3 mm id × 5 mm, 5 μm, Dionex) at 10 μL/min for 15 min, then peptides were separated on a 75 μm id × 50 cm PepMap RSLC column (Dionex, 2 μm) over a 120 min linear gradient of 4–32% CH3CN/0.1% FA at a flow rate at 300 nL/min. The LTQ Orbitrap Velos was operated in the “Top 10” data-dependant acquisition mode. The 10 most abundant and multiply-charged precursor ions in the MS survey scan in the Orbitrap (m/z 400 – 1500, with the lock mass at 445.120025) were dynamically selected for collision induced dissociation fragmentation (MS/MS) in the LTQ Velos ion trap. The ions must have a minimal signal above 2000 counts. The preview mode of FT master scan was disabled. The Orbitrap resolution was set at 60,000 at m/z 400 with one microscans. The isolation width for the precursor ion was set at 2 Th. The normalized collision energy was set at 35% with activation Q at 0.250 and activation time for 10 msec. The dynamic exclusion mass width was set at ±20 ppm and exclusion duration for 60 seconds. To achieve high mass accuracy, the AGC (Automatic Gain Control) were set at 1 × 106 for the full MS survey in the Orbitrap with a maximum injection time at 100 msec, and 5000 for the MS/MS in the LTQ Velos with a maximum injection time at 300 msec.
Protein identification and quantification
The raw files were processed with MaxQuant Software (version 18.104.22.168, http://maxquant.org) for protein identification and quantification. The Andromeda search engine was used to search the MS/MS spectra using the following parameters: trypsin/P with maximum 2 missed cleavages sites; peptide mass tolerance at first search was set at 20 ppm; MS/MS fragment mass tolerance at 0.49 Da, and top 6 MS/MS peaks per 100 Da and a minimum peptide length of 6 amino acids were required. The mass accuracy of the precursor ions was improved by the time-dependent recalibration algorithm of MaxQuant. Fixed modification for Carbamidomethyl and variable modifications for Deamidated (NQ) and Oxidation (M) were used, and a maximum of three labelled amino acids per peptide were allowed. The protein databases were extracted from annotated genome databases of C. difficile 630 (June 2013), and the contaminant database was supplemented by MaxQuant.
False discovery rates (FDR) were estimated based on matches to reversed sequences in the concatenated target-decoy database, and an FDR threshold of 1% was used for proteins and peptides. Peptides were assigned to protein groups, a cluster of a leading protein(s) plus additional proteins matching to a subset of the same peptides. Protein groups with posterior error probability (PEP) values over 0.01 or matches to reversed database or contaminants were discarded. Protein identification was reported for protein groups with at least one unique peptide.
MaxQuant normalized protein ratios of the C. difficile spo0A mutant over the parental C. difficile 630Δerm strain were converted to Log2 values. For each sample with three technical replicates, the Log2 protein ratio used was derived from the mean value of three repeat analyses. The final Log2 protein ratios reported represents the mean values of three biological replicates, and only values with at least three ratio counts were used. The protein group ratios from three biological replicates were also analyzed in Perseus (version 22.214.171.124), using the Significance B method which considered both the protein ratio and intensities of the peptide ions. Protein groups that were positive in Significance B tests of at least two biological replicates are reported as significant.
Transmission electron microscopy
Grids were prepared by briefly submerging slides into Formvar (0.1%) in dry chloroform. Formvar-carbon-coated support films were then floated onto distilled water, after which grids were placed onto the film before lifting onto parafilm and air-drying. Fresh bacterial colonies were picked, suspended in ammonium acetate and loaded onto the film side of the grid. An equal volume of ammonium molybdate (1%) was added to the film and immediately drained with filter paper. Samples were allowed to air-dry and were visualised via TEM as described above.
Culture supernatants of exponentially growing C. difficile 630∆erm strains were acidified, converted to t-butyldimethylsilyl derivatives as previously described and quantified by capillary gas chromatography . Butyrate quantification was performed in triplicate.
Availability of supporting data
The updated annotation for Clostridium difficile 630 described in this study is available in the main genomic sequence repositories under the accession number AM180355 (http://www.ebi.ac.uk/ena/data/view/am180355) and at http://www.sanger.ac.uk/resources/downloads/bacteria/clostridium-difficile.html. Fastq files from RNAseq analysis are available in ArrayExpress under the accession number E-ERAD-97 (http://www.ebi.ac.uk/arrayexpress/experiments/E-ERAD-97/).
Stage 0 sporulation protein A
Dodecyl sulfate polyacrylamide gel electrophoresis
False discovery rate
Transmission electron microscopy.
This project was funded by the Wellcome Trust (grants 098051 and 086418) and a Medical Research Council New Investigator Research Grant (TDL; grant 93614). HJF and SHD receive support from the Scottish Government Food, Land and People programme. WKS was supported by a Gisela Thier Fellowship and a VENI fellowship of the Netherlands Organisation for Scientific Research (NWO-ZonMW).
- Clements AC, Magalhaes RJ, Tatem AJ, Paterson DL, Riley TV: Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread. Lancet Infect Dis. 2010, 10 (6): 395-404. 10.1016/S1473-3099(10)70080-3.PubMedView Article
- Walker AS, Eyre DW, Wyllie DH, Dingle KE, Harding RM, O’Connor L, Griffiths D, Vaughan A, Finney J, Wilcox MH, Crook DW, Peto TE: Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. PLoS Med. 2012, 9 (2): e1001172-10.1371/journal.pmed.1001172.PubMed CentralPubMedView Article
- He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, Connor TR, Harris SR, Fairley D, Bamford KB, D'Arc S, Brazier J, Brown D, Coia JE, Douce G, Gerding D, Kim HJ, Koh TH, Kato H, Senoh M, Louie T, Michell S, Butt E, Peacock SJ, Brown NM, Riley T, Songer G, Wilcox M, Pirmohamed M, Kuijper E, et al: Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat Genet. 2012, 45 (1): 109-113. 10.1038/ng.2478.PubMed CentralPubMedView Article
- He M, Sebaihia M, Lawley TD, Stabler RA, Dawson LF, Martin MJ, Holt KE, Seth-Smith HM, Quail MA, Rance R, Brooks K, Churcher C, Harris D, Bentley SD, Burrows C, Clark L, Corton C, Murray V, Rose G, Thurston S, van Tonder A, Walker D, Wren BW, Dougan G, Parkhill J: Evolutionary dynamics of Clostridium difficile over short and long time scales. Proc Natl Acad Sci USA. 2010, 107 (16): 7527-7532. 10.1073/pnas.0914322107.PubMed CentralPubMedView Article
- Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, Stabler R, Thomson NR, Roberts AP, Cerdeno-Tarraga AM, Wang H, Holden MT, Wright A, Churcher C, Quail MA, Baker S, Bason N, Brooks K, Chillingworth T, Cronin A, Davis P, Dowd L, Fraser A, Feltwell T, Hance Z, Holroyd S, Jagels K, Moule S, Mungall K, Price C, Rabbinowitsch E, et al: The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat Genet. 2006, 38 (7): 779-786. 10.1038/ng1830.PubMedView Article
- Stabler RA, He M, Dawson L, Martin M, Valiente E, Corton C, Lawley TD, Sebaihia M, Quail MA, Rose G, Gerding DN, Gibert M, Popoff MR, Parkhill J, Dougan G, Wren BW: Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol. 2009, 10 (9): R102-10.1186/gb-2009-10-9-r102.PubMed CentralPubMedView Article
- Gerding DN: Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: this is an antimicrobial resistance problem. Clin Infect Dis. 2004, 38 (5): 646-648. 10.1086/382084.PubMedView Article
- Kelly CP, Kyne L: The host immune response to Clostridium difficile. J Med Microbiol. 2011, 60 (Pt 8): 1070-1079.PubMedView Article
- Chang JY, Antonopoulos DA, Kalra A, Tonelli A, Khalife WT, Schmidt TM, Young VB: Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea. J Infect Dis. 2008, 197 (3): 435-438. 10.1086/525047.PubMedView Article
- Wilcox MH, Fraise AP, Bradley CR, Walker J, Finch RG: Sporicides for Clostridium difficile: the devil is in the detail. J Hosp Infect. 2011, 77 (3): 187-188. 10.1016/j.jhin.2010.10.017.PubMedView Article
- Paredes CJ, Alsaker KV, Papoutsakis ET: A comparative genomic view of clostridial sporulation and physiology. Nat Rev Microbiol. 2005, 3 (12): 969-978. 10.1038/nrmicro1288.PubMedView Article
- Chastanet A, Vitkup D, Yuan GC, Norman TM, Liu JS, Losick RM: Broadly heterogeneous activation of the master regulator for sporulation in Bacillus subtilis. Proc Natl Acad Sci USA. 2010, 107 (18): 8486-8491. 10.1073/pnas.1002499107.PubMed CentralPubMedView Article
- Galperin MY, Mekhedov SL, Puigbo P, Smirnov S, Wolf YI, Rigden DJ: Genomic determinants of sporulation in Bacilli and Clostridia: towards the minimal set of sporulation-specific genes. Environ Microbiol. 2012, 14 (11): 2870-2890. 10.1111/j.1462-2920.2012.02841.x.PubMed CentralPubMedView Article
- Heap JT, Pennington OJ, Cartman ST, Carter GP, Minton NP: The ClosTron: a universal gene knock-out system for the genus Clostridium. J Microbiol Methods. 2007, 70 (3): 452-464. 10.1016/j.mimet.2007.05.021.PubMedView Article
- Underwood S, Guan S, Vijayasubhash V, Baines SD, Graham L, Lewis RJ, Wilcox MH, Stephenson K: Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production. J Bacteriol. 2009, 191 (23): 7296-7305. 10.1128/JB.00882-09.PubMed CentralPubMedView Article
- Hahn J, Roggiani M, Dubnau D: The major role of Spo0A in genetic competence is to downregulate abrB, an essential competence gene. J Bacteriol. 1995, 177 (12): 3601-3605.PubMed CentralPubMed
- Hamon MA, Lazazzera BA: The sporulation transcription factor Spo0A is required for biofilm development in Bacillus subtilis. Mol Microbiol. 2001, 42 (5): 1199-1209.PubMedView Article
- Lucking G, Dommel MK, Scherer S, Fouet A, Ehling-Schulz M: Cereulide synthesis in emetic Bacillus cereus is controlled by the transition state regulator AbrB, but not by the virulence regulator PlcR. Microbiology. 2009, 155 (Pt 3): 922-931.PubMedView Article
- Saile E, Koehler TM: Control of anthrax toxin gene expression by the transition state regulator abrB. J Bacteriol. 2002, 184 (2): 370-380. 10.1128/JB.184.2.370-380.2002.PubMed CentralPubMedView Article
- Alsaker KV, Spitzer TR, Papoutsakis ET: Transcriptional analysis of spo0A overexpression in Clostridium acetobutylicum and its effect on the cell’s response to butanol stress. J Bacteriol. 2004, 186 (7): 1959-1971. 10.1128/JB.186.7.1959-1971.2004.PubMed CentralPubMedView Article
- Rosenbusch KE, Bakker D, Kuijper EJ, Smits WK: C. difficile 630Deltaerm Spo0A regulates sporulation, but does not contribute to toxin production, by direct high-affinity binding to target DNA. PloS One. 2012, 7 (10): e48608-10.1371/journal.pone.0048608.PubMed CentralPubMedView Article
- Mackin KE, Carter GP, Howarth P, Rood JI, Lyras D: Spo0A differentially regulates toxin production in evolutionarily diverse strains of clostridium difficile. PloS One. 2013, 8 (11): e79666-10.1371/journal.pone.0079666.PubMed CentralPubMedView Article
- Deakin LJ, Clare S, Fagan RP, Dawson LF, Pickard DJ, West MR, Wren BW, Fairweather NF, Dougan G, Lawley TD: Clostridium difficile spo0A gene is a persistence and transmission factor. Infect Immun. 2012, 80 (8): 2704-2711. 10.1128/IAI.00147-12.PubMed CentralPubMedView Article
- Dawson LF, Valiente E, Faulds-Pain A, Donahue EH, Wren BW: Characterisation of Clostridium difficile biofilm formation, a role for Spo0A. PloS One. 2012, 7 (12): e50527-10.1371/journal.pone.0050527.PubMed CentralPubMedView Article
- Ethapa T, Leuzzi R, Ng YK, Baban ST, Adamo R, Kuehne SA, Scarselli M, Minton NP, Serruto D, Unnikrishnan M: Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile. J Bacteriol. 2013, 195 (3): 545-555. 10.1128/JB.01980-12.PubMed CentralPubMedView Article
- Wilson KH, Kennedy MJ, Fekety FR: Use of sodium taurocholate to enhance spore recovery on a medium selective for Clostridium difficile. J Clin Microbiol. 1982, 15 (3): 443-446.PubMed CentralPubMed
- Lawley TD, Croucher NJ, Yu L, Clare S, Sebaihia M, Goulding D, Pickard DJ, Parkhill J, Choudhary J, Dougan G: Proteomic and genomic characterization of highly infectious Clostridium difficile 630 spores. J Bacteriol. 2009, 191 (17): 5377-5386. 10.1128/JB.00597-09.PubMed CentralPubMedView Article
- Fimlaid KA, Bond JP, Schutz KC, Putnam EE, Leung JM, Lawley TD, Shen A: Global analysis of the sporulation pathway of clostridium difficile. PLoS Genet. 2013, 9 (8): e1003660-10.1371/journal.pgen.1003660.PubMed CentralPubMedView Article
- Pereira FC, Saujet L, Tome AR, Serrano M, Monot M, Couture-Tosi E, Martin-Verstraete I, Dupuy B, Henriques AO: The spore differentiation pathway in the enteric pathogen Clostridium difficile. PLoS Genet. 2013, 9 (10): e1003782-10.1371/journal.pgen.1003782.PubMed CentralPubMedView Article
- Monot M, Boursaux-Eude C, Thibonnier M, Vallenet D, Moszer I, Medigue C, Martin-Verstraete I, Dupuy B: Reannotation of the genome sequence of Clostridium difficile strain 630. J Med Microbiol. 2011, 60 (Pt 8): 1193-1199.PubMedView Article
- Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, Boursnell C, Pang N, Forslund K, Ceric G, Clements J, Heger A, Holm L, Sonnhammer EL, Eddy SR, Bateman A, Finn RD: The Pfam protein families database. Nucleic Acids Res. 2012, 40 (Database issue): D290-D301.PubMed CentralPubMedView Article
- Sigrist CJ, Cerutti L, de Castro E, Langendijk-Genevaux PS, Bulliard V, Bairoch A, Hulo N: PROSITE, a protein domain database for functional characterization and annotation. Nucleic Acids Res. 2010, 38 (Database issue): D161-D166.PubMed CentralPubMedView Article
- Petersen TN, Brunak S, von Heijne G, Nielsen H: SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods. 2011, 8 (10): 785-786. 10.1038/nmeth.1701.PubMedView Article
- Sonnhammer EL, von Heijne G, Krogh A: A hidden Markov model for predicting transmembrane helices in protein sequences. Proc Int Conf Intell Syst Mol Biol. 1998, 6: 175-182.PubMed
- Riley M: Functions of the gene products of Escherichia coli. Microbiol Rev. 1993, 57 (4): 862-952.PubMed CentralPubMed
- Permpoonpattana P, Tolls EH, Nadem R, Tan S, Brisson A, Cutting SM: Surface layers of Clostridium difficile endospores. J Bacteriol. 2011, 193 (23): 6461-6470. 10.1128/JB.05182-11.PubMed CentralPubMedView Article
- Permpoonpattana P, Phetcharaburanin J, Mikelsone A, Dembek M, Tan S, Brisson MC, La Ragione R, Brisson AR, Fairweather N, Hong HA, Cutting SM: Functional characterization of Clostridium difficile spore coat proteins. J Bacteriol. 2013, 195 (7): 1492-1503. 10.1128/JB.02104-12.PubMed CentralPubMedView Article
- Braun V, Mehlig M, Moos M, Rupnik M, Kalt B, Mahony DE, von Eichel-Streiber C: A chimeric ribozyme in Clostridium difficile combines features of group I introns and insertion elements. Mol Microbiol. 2000, 36 (6): 1447-1459.PubMedView Article
- Hasselmayer O, Braun V, Nitsche C, Moos M, Rupnik M, von Eichel-Streiber C: Clostridium difficile IStron CdISt1: discovery of a variant encoding two complete transposase-like proteins. J Bacteriol. 2004, 186 (8): 2508-2510. 10.1128/JB.186.8.2508-2510.2004.PubMed CentralPubMedView Article
- Haraldsen JD, Sonenshein AL: Efficient sporulation in Clostridium difficile requires disruption of the sigmaK gene. Mol Microbiol. 2003, 48 (3): 811-821. 10.1046/j.1365-2958.2003.03471.x.PubMedView Article
- Fagan RP, Janoir C, Collignon A, Mastrantonio P, Poxton IR, Fairweather NF: A proposed nomenclature for cell wall proteins of Clostridium difficile. J Med Microbiol. 2011, 60 (Pt 8): 1225-1228.PubMedView Article
- McBride SM, Sonenshein AL: Identification of a genetic locus responsible for antimicrobial peptide resistance in Clostridium difficile. Infect Immun. 2011, 79 (1): 167-176. 10.1128/IAI.00731-10.PubMed CentralPubMedView Article
- Suarez JM, Edwards AN, McBride SM: The Clostridium difficile cpr locus is regulated by a noncontiguous two-component system in response to type a and B lantibiotics. J Bacteriol. 2013, 195 (11): 2621-2631. 10.1128/JB.00166-13.PubMed CentralPubMedView Article
- Ho TD, Ellermeier CD: PrsW is required for colonization, resistance to antimicrobial peptides, and expression of extracytoplasmic function sigma factors in Clostridium difficile. Infect Immun. 2011, 79 (8): 3229-3238. 10.1128/IAI.00019-11.PubMed CentralPubMedView Article
- Tomas CA, Alsaker KV, Bonarius HP, Hendriksen WT, Yang H, Beamish JA, Paredes CJ, Papoutsakis ET: DNA array-based transcriptional analysis of asporogenous, nonsolventogenic Clostridium acetobutylicum strains SKO1 and M5. J Bacteriol. 2003, 185 (15): 4539-4547. 10.1128/JB.185.15.4539-4547.2003.PubMed CentralPubMedView Article
- Higgins D, Dworkin J: Recent progress in Bacillus subtilis sporulation. FEMS Microbiol Rev. 2012, 36 (1): 131-148. 10.1111/j.1574-6976.2011.00310.x.PubMed CentralPubMedView Article
- Shafikhani SH, Mandic-Mulec I, Strauch MA, Smith I, Leighton T: Postexponential regulation of sin operon expression in Bacillus subtilis. J Bacteriol. 2002, 184 (2): 564-571. 10.1128/JB.184.2.564-571.2002.PubMed CentralPubMedView Article
- Francis MB, Allen CA, Shrestha R, Sorg JA: Bile acid recognition by the Clostridium difficile germinant receptor, CspC, is important for establishing infection. PLoS Pathog. 2013, 9 (5): e1003356-10.1371/journal.ppat.1003356.PubMed CentralPubMedView Article
- Putnam EE, Nock AM, Lawley TD, Shen A: SpoIVA and SipL are Clostridium difficile spore morphogenetic proteins. J Bacteriol. 2013, 195 (6): 1214-1225. 10.1128/JB.02181-12.PubMed CentralPubMedView Article
- Saujet L, Pereira FC, Serrano M, Soutourina O, Monot M, Shelyakin PV, Gelfand MS, Dupuy B, Henriques AO, Martin-Verstraete I: Genome-wide analysis of cell type-specific gene transcription during spore formation in Clostridium difficile. PLoS Genet. 2013, 9 (10): e1003756-10.1371/journal.pgen.1003756.PubMed CentralPubMedView Article
- Zhang B, Daniel RA, Errington J, Kroos L: Bacillus subtilis SpoIIID protein binds to two sites in the spoVD promoter and represses transcription by sigmaE RNA polymerase. J Bacteriol. 1997, 179 (3): 972-975.PubMed CentralPubMed
- Cartman ST, Minton NP: A mariner-based transposon system for in vivo random mutagenesis of Clostridium difficile. Appl Environ Microbiol. 2010, 76 (4): 1103-1109. 10.1128/AEM.02525-09.PubMed CentralPubMedView Article
- Bouillaut L, Self WT, Sonenshein AL: Proline-dependent regulation of Clostridium difficile Stickland metabolism. J Bacteriol. 2013, 195 (4): 844-854. 10.1128/JB.01492-12.PubMed CentralPubMedView Article
- Dineen SS, McBride SM, Sonenshein AL: Integration of metabolism and virulence by Clostridium difficile CodY. J Bacteriol. 2010, 192 (20): 5350-5362. 10.1128/JB.00341-10.PubMed CentralPubMedView Article
- Antunes A, Martin-Verstraete I, Dupuy B: CcpA-mediated repression of Clostridium difficile toxin gene expression. Mol Microbiol. 2011, 79 (4): 882-899. 10.1111/j.1365-2958.2010.07495.x.PubMedView Article
- Mani N, Dupuy B: Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc Natl Acad Sci USA. 2001, 98 (10): 5844-5849. 10.1073/pnas.101126598.PubMed CentralPubMedView Article
- Hundsberger T, Braun V, Weidmann M, Leukel P, Sauerborn M, von Eichel-Streiber C: Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur J Biochem/FEBS. 1997, 244 (3): 735-742. 10.1111/j.1432-1033.1997.t01-1-00735.x.View Article
- Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E, McDonald LC: Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet. 2005, 366 (9491): 1079-1084. 10.1016/S0140-6736(05)67420-X.PubMedView Article
- McBride SM, Sonenshein AL: The dlt operon confers resistance to cationic antimicrobial peptides in Clostridium difficile. Microbiology. 2011, 157 (Pt 5): 1457-1465.PubMed CentralPubMedView Article
- Twine SM, Reid CW, Aubry A, McMullin DR, Fulton KM, Austin J, Logan SM: Motility and flagellar glycosylation in Clostridium difficile. J Bacteriol. 2009, 191 (22): 7050-7062. 10.1128/JB.00861-09.PubMed CentralPubMedView Article
- Aboulnaga EH, Pinkenburg O, Schiffels J, El-Refai A, Buckel W, Selmer T: Butyrate production in Escherichia coli: Exploitation of an oxygen tolerant bifurcating butyryl-CoA dehydrogenase/electron transferring flavoprotein complex from Clostridium difficile. J Bacteriol. 2013, 195 (16): 3704-3713. 10.1128/JB.00321-13.PubMed CentralView Article
- Lawley TD, Clare S, Walker AW, Goulding D, Stabler RA, Croucher N, Mastroeni P, Scott P, Raisen C, Mottram L, Fairweather NF, Wren BW, Parkhill J, Dougan G: Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect Immun. 2009, 77 (9): 3661-3669. 10.1128/IAI.00558-09.PubMed CentralPubMedView Article
- Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C, Lawley TD, Clare S, Walker AW, Stares MD, Connor TR, Raisen C, Goulding D, Rad R, Schreiber F, Brandt C, Deakin LJ, Pickard DJ, Duncan SH, Flint HJ, Clark TG, Parkhill J, Dougan G: Targeted Restoration of the Intestinal Microbiota with a Simple, Defined Bacteriotherapy Resolves Relapsing Clostridium difficile Disease in Mice. PLoS Pathog. 2012, 8 (10): e1002995-10.1371/journal.ppat.1002995.PubMed CentralPubMedView Article
- Johansson ME, Larsson JM, Hansson GC: The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci USA. 2011, 108 (Suppl 1): 4659-4665.PubMed CentralPubMedView Article
- Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ: Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 2008, 27 (2): 104-119.PubMedView Article
- Harris LM, Welker NE, Papoutsakis ET: Northern, morphological, and fermentation analysis of spo0A inactivation and overexpression in Clostridium acetobutylicum ATCC 824. J Bacteriol. 2002, 184 (13): 3586-3597. 10.1128/JB.184.13.3586-3597.2002.PubMed CentralPubMedView Article
- Chen X, Katchar K, Goldsmith JD, Nanthakumar N, Cheknis A, Gerding DN, Kelly CP: A Mouse Model of Clostridium difficile-Associated Disease. Gastroenterology. 2008, 135 (6): 1984-1992. 10.1053/j.gastro.2008.09.002.PubMedView Article
- Theriot CM, Koumpouras CC, Carlson PE, Bergin II, Aronoff DM, Young VB: Cefoperazone-treated mice as an experimental platform to assess differential virulence of Clostridium difficile strains. Gut Microbes. 2011, 2 (6): 326-334. 10.4161/gmic.19142.PubMed CentralPubMedView Article
- Martin MJ, Clare S, Goulding D, Faulds-Pain A, Barquist L, Browne HP, Pettit L, Dougan G, Lawley TD, Wren BW: The agr locus regulates virulence and colonization genes in Clostridium difficile 027. J Bacteriol. 2013, 195 (16): 3672-3681. 10.1128/JB.00473-13.PubMed CentralPubMedView Article
- Croucher NJ, Fookes MC, Perkins TT, Turner DJ, Marguerat SB, Keane T, Quail MA, He M, Assefa S, Bahler J, Kingsley RA, Parkhill J, Bentley SD, Dougan G, Thomson NR: A simple method for directional transcriptome sequencing using Illumina technology. Nucleic Acids Res. 2009, 37 (22): e148-10.1093/nar/gkp811.PubMed CentralPubMedView Article
- Anders S, Huber W: Differential expression analysis for sequence count data. Genome Biol. 2010, 11 (10): R106-10.1186/gb-2010-11-10-r106.PubMed CentralPubMedView Article
- Boersema PJ, Aye TT, van Veen TA, Heck AJ, Mohammed S: Triplex protein quantification based on stable isotope labeling by peptide dimethylation applied to cell and tissue lysates. Proteomics. 2008, 8 (22): 4624-4632. 10.1002/pmic.200800297.PubMedView Article
- Richardson AJ, Calder AG, Stewart CS, Smith A: Simultaneous determination of volatile and non-volatile acidic fermentation products of anaerobes by capillary gas chromatography. Lett Appl Microbiol. 1989, 9 (1): 5-8. 10.1111/j.1472-765X.1989.tb00278.x.View Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.